LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | SNS-032 | 3.33 | uM | LJP6 | 1 | H14 | 72 | hr | 765 | 449 | 3143 | 0.1428 | -0.2300 |
Hs 578T | SNS-032 | 3.33 | uM | LJP6 | 2 | H14 | 72 | hr | 765 | 415 | 3095 | 0.1341 | -0.2616 |
Hs 578T | SNS-032 | 3.33 | uM | LJP6 | 3 | H14 | 72 | hr | 765 | 429 | 3066 | 0.1399 | -0.2509 |
Hs 578T | SNS-032 | 10 | uM | LJP6 | 1 | H13 | 72 | hr | 765 | 383 | 3143 | 0.1218 | -0.2878 |
Hs 578T | SNS-032 | 10 | uM | LJP6 | 2 | H13 | 72 | hr | 765 | 419 | 3095 | 0.1354 | -0.2581 |
Hs 578T | SNS-032 | 10 | uM | LJP6 | 3 | H13 | 72 | hr | 765 | 397 | 3066 | 0.1295 | -0.2793 |
Hs 578T | Afatinib | 0.04 | uM | LJP6 | 1 | G24 | 72 | hr | 765 | 3036 | 3143 | 0.9657 | 0.9661 |
Hs 578T | Afatinib | 0.04 | uM | LJP6 | 2 | G24 | 72 | hr | 765 | 2861 | 3095 | 0.9242 | 0.9233 |
Hs 578T | Afatinib | 0.04 | uM | LJP6 | 3 | G24 | 72 | hr | 765 | 2902 | 3066 | 0.9465 | 0.9459 |
Hs 578T | Afatinib | 0.12 | uM | LJP6 | 1 | G23 | 72 | hr | 765 | 2933 | 3143 | 0.9330 | 0.9331 |
Hs 578T | Afatinib | 0.12 | uM | LJP6 | 2 | G23 | 72 | hr | 765 | 2811 | 3095 | 0.9081 | 0.9066 |
Hs 578T | Afatinib | 0.12 | uM | LJP6 | 3 | G23 | 72 | hr | 765 | 2885 | 3066 | 0.9410 | 0.9402 |
Hs 578T | Afatinib | 0.37 | uM | LJP6 | 1 | G22 | 72 | hr | 765 | 3034 | 3143 | 0.9651 | 0.9654 |
Hs 578T | Afatinib | 0.37 | uM | LJP6 | 2 | G22 | 72 | hr | 765 | 2795 | 3095 | 0.9029 | 0.9012 |
Hs 578T | Afatinib | 0.37 | uM | LJP6 | 3 | G22 | 72 | hr | 765 | 2822 | 3066 | 0.9204 | 0.9189 |
Hs 578T | Afatinib | 1.11 | uM | LJP6 | 1 | G21 | 72 | hr | 765 | 2800 | 3143 | 0.8907 | 0.8896 |
Hs 578T | Afatinib | 1.11 | uM | LJP6 | 2 | G21 | 72 | hr | 765 | 2671 | 3095 | 0.8628 | 0.8589 |
Hs 578T | Afatinib | 1.11 | uM | LJP6 | 3 | G21 | 72 | hr | 765 | 2657 | 3066 | 0.8666 | 0.8620 |
Hs 578T | Afatinib | 3.33 | uM | LJP6 | 1 | G20 | 72 | hr | 765 | 2466 | 3143 | 0.7844 | 0.7754 |
Hs 578T | Afatinib | 3.33 | uM | LJP6 | 2 | G20 | 72 | hr | 765 | 2484 | 3095 | 0.8024 | 0.7932 |
Hs 578T | Afatinib | 3.33 | uM | LJP6 | 3 | G20 | 72 | hr | 765 | 2638 | 3066 | 0.8604 | 0.8554 |
Hs 578T | Afatinib | 10 | uM | LJP6 | 1 | G19 | 72 | hr | 765 | 504 | 3143 | 0.1603 | -0.1851 |
Hs 578T | Afatinib | 10 | uM | LJP6 | 2 | G19 | 72 | hr | 765 | 458 | 3095 | 0.1480 | -0.2246 |
Hs 578T | Afatinib | 10 | uM | LJP6 | 3 | G19 | 72 | hr | 765 | 511 | 3066 | 0.1667 | -0.1825 |
Hs 578T | GSK1904529A | 0.04 | uM | LJP6 | 1 | H24 | 72 | hr | 765 | 3019 | 3143 | 0.9603 | 0.9607 |